A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2006
12/06/2006	CN1872026A New medicinal preparation for vagina
12/06/2006	CN1288243C PEG-modified uricase
12/06/2006	CN1287868C Pressure-sensitive adhesive sheet for medical use and process for producing the same
12/06/2006	CN1287859C Magnetic targeted carrier composed of iron and porous materials for targeted delivery of biologically active agents
12/06/2006	CN1287804C Suspension of Fe#-[3]O#-[4] microparticle and iodized oil for treating liver and kidney tumor by embolizing and its preparation process
12/06/2006	CN1287798C Method for preparing long acting progestational hormone injection embedded agent and use
12/06/2006	CN1287791C Combination of semisolid framework preparation of nimodipine
12/06/2006	CN1287782C Stable solid dosage forms of amino acids and processes for producing same
12/06/2006	CN1287780C Orodispersible pharmaceutical composition of agomelatine
12/06/2006	CN1287776C Process for preparing houttuyninum sodium injection
12/06/2006	CN1287774C Composition for inhalation
12/06/2006	CN1287770C Pharmaceutical compositions in particulate form
12/06/2006	CN1287769C Dispersible phospholipid stabilzed microparticles
12/06/2006	CN1287768C Stabilized oral suspension formulation
12/05/2006	US7145039 Transfection reagents
12/05/2006	US7144991 Use of fusion proteins, especially scFvSA, as diagnostic markers or as cell specific targeting agents.
12/05/2006	US7144978 Multidrop tree branching functional polyethylene glycol, methods of preparing and using same
12/05/2006	US7144922 By administering a glycol derivative, specifically diethylene glycol dibenzoate controlling replication of HIV by exposing an infected cell to said glycol derivative
12/05/2006	US7144919 Polyoxyethylene-polyoxypropylene vitamin E and process for preparation thereof
12/05/2006	US7144877 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
12/05/2006	US7144873 Therapy for anticancer agents, blood disorders; dissolving in nonaqueous solvent
12/05/2006	US7144863 Powders of glucagon-like peptide is complexed with a polypeptide of polylysine, polyarginine, polyornithine, protamine, putrescine, spermine, spermidine, and histone; treating diabetes, hyperglycemia, obesity, irritable bowel syndrome, myocardial infarction; drug delivery by inhalation
12/05/2006	US7144861 Stabilized teriparatide solutions
12/05/2006	US7144860 Amd to ischemic tissue; treating atherosclerosis and restenosis.
12/05/2006	US7144855 Protein complex from ion-exchange chromatography for treatment of bacterial infections
12/05/2006	US7144574 For therapy of multiple sclerosis
12/05/2006	US7144573 Acrylamide or N-vinyl-2-pyrrolidone copolymer with fatty acid-containing comonomer has end group comprising N-(2-Mercaptoethyl)-3,5-bis(4-benzoylbenzyloxy)benzamide; holds and positions albumin; passivation of biocompatible, tissue-contacting surfaces
12/05/2006	CA2351730C Antiparasitic formulations containing avermectin 13-monosaccharide 5-oxime
12/05/2006	CA2296710C Improved multiparticulate tablet with quick disintegration
12/05/2006	CA2290624C Gastric-retentive oral drug dosage forms for controlled release of highly soluble drugs
12/05/2006	CA2218860C Apparatus and method for making gas-filled vesicles of optimal size
12/05/2006	CA2214788C Controlled dissolution pellet containing calcium sulfate
12/05/2006	CA2176604C Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin
12/05/2006	CA2142530C Topical compositions containing benzoyl peroxide and clindamycin and method of use thereof
12/05/2006	CA2130787C Ursodeoxycholic acid-containing medicament in a liquid administration form
12/05/2006	CA2129921C Stable aqueous solutions of hybrid .alpha.-interferon bdbb
12/05/2006	CA2078679C Magnetic metal oxide ultrafine particles-containing composition
11/2006
11/30/2006	WO2006127424A2 Methods for promoting health or wellness in adult animals
11/30/2006	WO2006127284A2 Method of purifying apo-2 ligand/trail using crystallisation in the cold
11/30/2006	WO2006127121A2 Polysaccharide and polyol composition for treating dry eye and related methods of manufacture and methods of use
11/30/2006	WO2006126681A1 Pharmaceutical composition
11/30/2006	WO2006126600A1 Pharmaceutical composition for vascular occlusive disease
11/30/2006	WO2006126244A1 Method of producing liposomes containing gas enclosed therein
11/30/2006	WO2006126034A1 Medicated product for local use based on natural materials
11/30/2006	WO2006125763A1 Stabilized polypeptide formulations
11/30/2006	WO2006125762A1 Stabilized polypeptide formulations
11/30/2006	WO2006125668A2 Anti-cd16 binding molecules
11/30/2006	WO2006125481A1 Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen
11/30/2006	WO2006109898A8 Antimicrobial composition containing natural extract, nano silver and natural essential oil
11/30/2006	WO2006108052A3 Peg and polysialic lysosomal enzyme conjugates via acid labile linkers for therapeutic targeting
11/30/2006	WO2006099514A3 Drug delivery compositions and related methods
11/30/2006	WO2006095029A3 Di-polymer protein conjugates and processes for their preparation
11/30/2006	WO2006089993B1 Method of obtaining hydrogels of cyclodextrins with glycidyl ethers, compositions thus obtained and applications thereof
11/30/2006	WO2006086325A3 Synthesis of homopolymers and block copolymers
11/30/2006	WO2005112888A3 Methods for making injectable polymer hydrogels
11/30/2006	US20060270830 Polysialic acid having a moiety linked at one or each terminal unit of a functional group of from N-maleimido, vinysulphone, N-iodoacetamide, and orthopyridyl disulphide; conjugation with protein or peptide having a cysteine to attach to the thiol;bioavailability; drug delivery
11/30/2006	US20060270829 G-csf conjugates
11/30/2006	US20060270717 Therapeutic combination
11/30/2006	US20060270703 G-csf conjugates
11/30/2006	US20060269912 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
11/30/2006	US20060269628 Composition for attenuation of pain or wound healing agents in dosage
11/30/2006	US20060269620 Zeolites for delivery of nitric oxide
11/30/2006	US20060269619 Nutrient system for individualized responsive dosing regimens
11/30/2006	US20060269604 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
11/30/2006	US20060269603 Controlled release tramadol formulations
11/30/2006	US20060269600 Enhancing bioavailability of oral immediate release tablets for low solubility medicants; respiratory inflammatory disorders
11/30/2006	US20060269599 Fast-dissolving pharmaceutical composition
11/30/2006	US20060269594 Liposomal antineoplastic drugs and uses thereof
11/30/2006	US20060269581 Stable water in oil aminophylline emulsions
11/30/2006	US20060269553 a protein conjugate comprising a physiologically active polypeptide, a non-peptide polymer and an immunoglobulin Fc fragment, with improved in vivo duration and stability; nonimmunogenic
11/30/2006	US20060269511 Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly
11/30/2006	US20060269487 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route
11/30/2006	US20060269478 Use of protein occlusion for the selective delivery of small molecules to targets
11/30/2006	US20060269477 ST receptor binding compounds and methods of using the same
11/30/2006	DE60119082T2 Anästhetikum enthaltende formulierungen Anesthetic formulations containing
11/30/2006	CA2726759A1 Human proislet peptide, derivatives and analogs thereof, and methods of using same
11/30/2006	CA2609682A1 Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen
11/30/2006	CA2609593A1 Anti-cd16 binding molecules
11/30/2006	CA2609373A1 Method of producing liposomes containing gas enclosed therein
11/30/2006	CA2609188A1 Apo-2 ligand/trail formulations
11/30/2006	CA2608036A1 Medicated product for local use based on natural materials
11/29/2006	EP1726650A1 Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen
11/29/2006	EP1726318A1 Medicine/gene leaching type stent
11/29/2006	EP1726306A1 Fasudil-containing preparation and method of improving stability thereof
11/29/2006	EP1725589A1 Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination
11/29/2006	EP1725586A2 Partially loaded antibodies and methods of their conjugation
11/29/2006	EP1725583A2 Methods for increasing protein polyethylene glycol (peg) conjugation
11/29/2006	EP1725520A2 Formulation auxiliary agents (aminopropanoic acid derivative) in cosmetic or dermatoligical preparations
11/29/2006	EP1725271A2 Reagents, methods and kits for use in deactivating nucleic acids
11/29/2006	EP1725267A2 Enzyme-prodrug therapy for prosthetic joint repair
11/29/2006	EP1725265A2 Calicheamicin conjugates by antibody deglycosylation
11/29/2006	EP1725264A2 Antibody calicheamicin conjugates for passive targeting
11/29/2006	EP1725263A1 Stable, palatable syrup containing ibuprofen and method of its preparation
11/29/2006	EP1725262A2 Polymer-based compositions and conjugates of hiv entry inhibitors
11/29/2006	EP1725252A2 Antitumour treatments with metxia-p450 and cyclophosphamide or 5t4 vaccine
11/29/2006	EP1725249A2 Monomethylvaline compounds capable of conjugation to ligands
11/29/2006	EP1725218A1 Pharmaceutical composition comprising pimobendan
11/29/2006	EP1725215A1 Method and apparatus for producing carrier complexes
11/29/2006	EP1480624B1 Pharmaceutical tablet
11/29/2006	EP1470152A4 Peptides for increasing transfection efficiency

1 ... 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 ... 1712